0001654954-21-001750.txt : 20210216 0001654954-21-001750.hdr.sgml : 20210216 20210216193511 ACCESSION NUMBER: 0001654954-21-001750 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210211 FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brown Michael J CENTRAL INDEX KEY: 0001035909 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 21641970 MAIL ADDRESS: STREET 1: C/O EURONET WORLDWIDE, INC. STREET 2: 11400 TOMAHAWK CREEK PARKWAY, SUITE 300 CITY: LEAWOOD STATE: KS ZIP: 66211 FORMER NAME: FORMER CONFORMED NAME: BROWN MICHAEL J DATE OF NAME CHANGE: 19970317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Halloran Thomas V. CENTRAL INDEX KEY: 0001727481 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 21641971 MAIL ADDRESS: STREET 1: C/O MONOPAR THERAPEUTICS INC. STREET 2: 1000 SKOKIE BLVD., SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Robinson Chandler CENTRAL INDEX KEY: 0001727334 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 21641972 MAIL ADDRESS: STREET 1: C/O SKOKIE BLVD., SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mazar Andrew Paul CENTRAL INDEX KEY: 0001727393 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 21641973 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD STREET 2: SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tactic Pharma LLC CENTRAL INDEX KEY: 0001727357 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 21641974 BUSINESS ADDRESS: STREET 1: 598 ROCKEFELLER RD. CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: 4158279929 MAIL ADDRESS: STREET 1: C/O SKOKIE BLVD., SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 BUSINESS PHONE: 8473880349 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2021-02-11 0001645469 Monopar Therapeutics MNPR 0001727357 Tactic Pharma LLC C/O 1000 SKOKIE BLVD, STE 350 WILMETTE IL 60091 false false true 0001727393 Mazar Andrew Paul C/O 1000 SKOKIE BLVD, STE 350 WILMETTE IL 60091 true true false Chief Scientific Officer 0001727334 Robinson Chandler C/O 1000 SKOKIE BLVD, STE 350 WILMETTE IL 60091 true true false Chief Executive Officer 0001727481 O'Halloran Thomas V. C/O 1000 SKOKIE BLVD, STE 350 WILMETTE IL 60091 false false true 0001035909 Brown Michael J C/O 1000 SKOKIE BLVD STE 350 WILMETTE IL 60091 true false false Common stock 2021-02-11 4 S false 42467 13.30 D 249200 D Common stock 2021-02-11 4 S false 24224 14.09 D 224976 D Common stock 2021-02-11 4 S false 29996 15.12 D 194980 D Common stock 2021-02-11 4 S false 16384 16.44 D 178596 D Common stock 2021-02-11 4 S false 11929 16.90 D 166667 D Common stock 4111272.88 I See Footnotes Trade made pursuant to a 10b5-1 plan executed on November 24, 2020. This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.66 to $13.65, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.66 to $14.54, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.76 to $15.75, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.77 to $16.76, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.77 to $17.01, inclusive. Tactic shares voting and investment power over 4,111,272.88 of the shares of common stock held by TacticGem LLC. /s/ Kim R. Tsuchimoto, Attorney-in-fact 2021-02-16 /s/ Kim R. Tsuchimoto, Attorney-in-fact 2021-02-16 /s/Kim R. Tsuchimoto, Attorney-in-fact 2021-02-16 /s/Kim R. Tsuchimoto, Attorney-in-fact 2021-02-16 /s/ Kim R. Tsuchimoto, Attorney-in-fact 2021-02-16